Hui-Chu Lang
National Yang-Ming University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hui-Chu Lang.
Health Economics | 2010
Takeru Shiroiwa; Yoon-Kyoung Sung; Takashi Fukuda; Hui-Chu Lang; Sang-Cheol Bae; Kiichiro Tsutani
Although the threshold of cost effectiveness of medical interventions is thought to be 20 000- 30 000 UK pounds in the UK, and
Alimentary Pharmacology & Therapeutics | 2003
Ching-Liang Lu; Chun-Chia Chen; Hui-Chu Lang; Jiing-Chyuan Luo; S.-S. Wang; Chang Fy; Shou-Dong Lee
50 000-
Scandinavian Journal of Gastroenterology | 2005
Ching-Liang Lu; Hui-Chu Lang; Full-Young Chang; Chih-Yen Chen; Jiing-Chyuan Luo; Sun-Sang Wang; Shou-Dong Lee
100 000 in the US, it is well known that these values are unjustified, due to lack of explicit scientific evidence. We measured willingness-to-pay (WTP) for one additional quality-adjusted life-year gained to determine the threshold of the incremental cost-effectiveness ratio. Our study used the Internet to compare WTP for the additional year of survival in a perfect status of health in Japan, the Republic of Korea (ROK), Taiwan, Australia, the UK, and the US. The research utilized a double-bound dichotomous choice, and analysis by the nonparametric Turnbull method. WTP values were JPY 5 million (Japan), KWN 68 million (ROK), NT
Alimentary Pharmacology & Therapeutics | 2005
Ching-Liang Lu; Chang Fy; Hui-Chu Lang; Chun-Chia Chen; Jiing-Chyuan Luo; Lee Sd
2.1 million (Taiwan), 23 000 UK pounds (UK), AU
Alimentary Pharmacology & Therapeutics | 2005
Ching-Liang Lu; Hui-Chu Lang; Chang Fy; Tzeng-Ji Chen; Chun-Chia Chen; Jiing-Chyuan Luo; Lee Sd
64 000 (Australia), and US
Health Policy | 2004
Hui-Chu Lang; Chunhuei Chi; Chi-Ming Liu
62 000 (US). The discount rates of outcome were estimated at 6.8% (Japan), 3.7% (ROK), 1.6% (Taiwan), 2.8% (UK), 1.9% (Australia), and 3.2% (US). Based on the current study, we suggest new classification of cost-effectiveness plane and methodology for decision making.
Hepatology | 2017
Chang Fy; Yen-Po Wang; Hui-Chu Lang; Chia-Fen Tsai; Ming-Chih Hou; Fa-Yauh Lee; Ching-Liang Lu
Background : Irritable bowel syndrome is a common condition seen in Western countries. In Asia, however, it is less known and even less studied.
Supportive Care in Cancer | 2010
Hui-Chu Lang; Ling-Hsiang Chuang; Shiow-Ching Shun; Ching-Lin Hsieh; Chung-Fu Lan
Objective Until now, the epidemiology of functional dyspepsia (FD) and its social impact on Asians have been rarely studied. The aims of this study were to determine the prevalence, social impact, and health-seeking behaviors of FD in an apparently healthy Chinese population in Taiwan. Material and methods Based on the questionnaire provided by the Rome II working team, a survey was administered to a Taiwanese population receiving paid physical check-up (n=2865). Esophagoduodenoscopy was performed in each subject to exclude organic dyspepsia. Finally, diagnoses of functional gastrointestinal disorders were obtained by means of a computer-generated algorithm. Results The FD prevalences were 23.8% and 11.8% according to the Rome I and -II criteria, respectively. Nearly 60% of Rome I-defined FD subjects and 18.9% of Rome II-defined FD subjects had overlapping irritable bowel syndrome (IBS). Irrespective of any Rome definition, FD subjects had excessive physician visits, absenteeism, and sleep disturbances compared to dyspepsia-free controls (p<0.01). Moreover, over half of the Rome II FD subjects were “consulters” showing excessive physician visits, absenteeism, and sleep disturbances than “non-consulters”. The dysmotility-like subgroup (74.5%) comprised the majority of FD subjects and showed no differences to their ulcer-like counterparts in terms of major demographic data and social and health impacts. Conclusions FD is a common complaint in Taiwan and also bears an obvious social and medical burden to society. Over half of our FD subjects sought medical help, which may be due to the readily accessible medical care in Taiwan. The newly defined Rome II criteria diminish the chance of co-existence of FD and IBS. Further FD classification by the main symptoms appears of limited clinical usefulness.
Applied Health Economics and Health Policy | 2008
Hui-Chu Lang; Jaw-Ching Wu; Sang-Hue Yen; Chung-Fu Lan; Shi-Liang Wu
Background : Little is known about the gender effect on irritable bowel syndrome in Asia.
International Journal of Rheumatic Diseases | 2014
Ying-Ming Chiu; Hui-Chu Lang; Hsiao-Yi Lin; Ming-Ta Yang; Chi-Hui Fang; Ya-Wen Yang; Vernon F. Schabert; Boxiong Tang
Background : Little is known about the social and medical burdens of heartburn in Asia.